Press release

Christophe Carissimo Appointed Director of EMEA Professional Services at Adents

The unit-level serialization and traceability software solutions company Adents has named Christophe Carissimo to the position of Director of EMEA (Europe, Middle East & Africa) Professional Services. Mr. Carissimo brings an in-depth knowledge of the pharmaceutical manufacturing environment and sound experience in the management of complex projects. He will be responsible for supporting Adents’ clients and partner network in the implementation of serialization projects.

With the upcoming regulatory deadlines pertaining to drug serialization and traceability in Europe and the United States, the pharmaceutical industry is seeking an operational software solution which is easy to configure and quick to deploy. The appointment of Mr. Carissimo reflects Adents’ objectives to accelerate integration of its software solution to enable pharma manufacturers to realize timely compliance.

“We will leverage Christophe’s deep expertise to assist our network of certified partners for the implementation of our Adents Seriza and Agents Prodigi solutions at customer facilities. His mission is to strengthen the EMEA Professional Services team, which is responsible for providing methodological and technical support,” said Christophe Devins, founder, Chair & CEO of Adents.

“Implementing serialization represents a complex challenge for pharma manufacturers. Without a software solution that can both fully adapt to the pharmaceutical industrial environment and meet ever-shifting regulatory requirements, risks of non-compliance or productivity drop-offs are real. ,” explained Mr. Carissimo. “The ease of integration, flexibility, reliability and upgradeability of Adents solutions are unrivalled in their abilities to meet the challenges of drug serialization.,” he added.

Mr. Carissimo brings to Adents more than 17 years of experience in senior operations management positions at pharmaceutical production sites. His solid background has enabled him to develop an in-depth understanding of logistics and production processes, with a specific focus on the topics of codification and digitalization.

As Supply Chain Director of Leo Pharma, Mr. Carissimo was, for instance, in charge of the digitalization of the company’s shipping system. Then he supervised the implementation of an Electronic Data Interchange (EDI) system and of the CIP 13 Datamatrix at Norgine Pharma, where he was also managing a site for six years. Lastly, Christophe was in charge of the “Serialization, Aggregation and Tamper-evidence” project at Sanofi’s Le Trait site in Normandy, France, where he coordinated the roll-out of these processes across 10 strategic production lines and oversaw the kick-off of the first line fully equipped with serialization.

For over 15 years, Mr. Carissimo has also been involved in several pharmaceutical industry organizations. He was a co-founder and board member of Polepharma, a regional industrial cluster in France, as well as a member of the Manufacturing Committee at the LEEM, the French pharmaceutical industry federation. He has also been a member of the Club Inter Pharmaceutique (CIP), a French association for the Pharma Industry, where he chaired the “Codification” Committee.

He now also represents Adents in working groups within GS1 Healthcare and ISPE on topics concerning patient safety.

Silvain Vernet


COVID-19: Adents' Business Continuity plan
The COVID-19 coronavirus epidemic has already affected thousands of people around the world and we expect the French government to announce stricter containment measures soon. Since Adents employees are mainly based in France and the United States, we take the health and economic risks linked to this epidemic very seriously.
Laboratoires Théa addresses European FMD and South Korea market regulation requirements with Adents Cloud serialization solution
Leading Ophtalmic Pharmaceuticals Company chose Adents Prodigi to connect with approximately 15 supply chain partners to stay compliant with current and future regulations.
Pharmascience Chooses Software from Adents to Ensure European FMD and US DSCSA Serialization Compliance Regulations
Pharmascience,the 4th largest manufacturer of over-the-counter and generic drugs in Canada, has chosen to partner with Adents, a leading provider of versatile and easily deployable serialization and track-and-trace software solutions, to assure compliance with the European Falsified Medicines Directive as well as the U.S. DSCSA serialization regulation.